Rare diseases
Investigational molecules
Locations
Back to Belgium217 clinical trials in Brugge, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection
BelgiumPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
BelgiumLong-Term Study of Imeroprubart in Adults With Graves' Disease
BelgiumA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
BelgiumA study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis
BelgiumStudy of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia
BelgiumA study to compare the effectiveness of EL219 against liposomal amphotericin B and voriconazole for patients with suspected invasive mould infections.
BelgiumStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
BelgiumA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
BelgiumA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
BelgiumA Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
BelgiumA study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on viral infections and preventive measures, including trials evaluating new vaccines against influenza and cytomegalovirus. Research also covers treatment approaches for hepatitis B and invasive fungal infections.
Innovative approaches in vaccine development and antimicrobial therapies are being tested to combat various infectious diseases.
Comprehensive research into blood cancers and solid tumors, including studies on multiple myeloma, leukemia, and gastric cancer. Novel therapeutic approaches combine targeted treatments with immunotherapy.
Advanced treatment protocols are being evaluated to improve patient outcomes in various cancer types.
Studies addressing cardiovascular disease, obesity, and type 2 diabetes. Research focuses on innovative treatments and prevention strategies for major cardiovascular events.
Trials aim to improve cardiovascular outcomes and metabolic health through novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
